|
|
|
|
|
| BC. December 1, 2009 PB, capecitabine, sorafenib, sirolimus, vorinostat |
|
| Regional radiology CT February 26, 2010 | SD | KRAS-mutated, Molecular profiling-negative (blood) |
| 12 | Cancer institute March 25, 2005 | Adenocarcinoma of the colon, invasive, moderately differentiated | Regional hospital CT March 2007 | Para-aortic lymphadenopathy | Anterior resection of the colon February 3, 2005 |
|
|
|
|
|
|
|
|
|
|
| FOLFOX May 2005-July 2005 |
|
|
|
|
|
|
| Cancer institute October 24, 2007 | Metastatic adenocarcinoma consistent with colorectal primary (retroauricular lymph node) |
|
| Irinotecan, capecitabine, BVZ November 2007 to March 2008 |
|
|
|
|
|
|
|
|
|
|
| Dendritic cell vaccine March 2008 | Cancer institute CT September 3, 2008 | Recurrence (periaortic lymph nodes) |
|
|
|
|
|
|
|
|
| Irinotecan, capecitabine, oxaliplatin, BVZ to October 2009 | Cancer institute PET/CT November 11, 2009 | Recurrence (adrenal glands, lungs, stomach) |
|
|
|
|
|
|
|
|
| BC. January 19, 2010 PB, sorafenib, sirolimus, vorinostat, BVZ, panitumumab. Discontinued May 15, 2010 |
|
| Regional radiology CT/PET June 15, 2010 | SD | Molecular profiling-negative (blood) |
| 13 | Regional hospital April 27, 2007 | Adenocarcinoma of the colon, poorly differentiated. Adenocarcinoma consistent with colorectal origin (liver biopsy) | Regional radiology PET/CT May 15, 2007 | Small nodule in the left lower lobe of the lung | Transverse colon resection April 25, 2007 |
|
|
|
|
|
|
|
|
|
|
| FOLFOX June 18, 2007 to November 26, 2007 | Regional hospital CT May 12, 2009 | Recurrence (liver) |
|
|
|
|
|
|
|
|
| Cetuximab July 2009 to September 2009 |
|
|
|
|
|
|
|
|
|
|
| Resection of liver metastases September 24, 2009 |
|
|
|
|
|
|
|
|
|
|
| Capecitabine and BVZ November 2009 to April 2010 | Regional radiology PET/CT April 25, 2011 | Recurrence (lungs) |
|
|
|
|
|
|
|
|
| Wedge resection of pulmonary nodules June 21, 2011 | Regional radiology CT/PET July 19, 2011 | Recurrence (lungs) |
|
|
|
|
|
|
|
|
| BC. August 29, 2011 PB, erlotinib, pazopanib, dasatinib |
|
| Regional radiology PET/CT November 22, 2011 | SD | VEGF-elevated (blood), KRAS-R164Q mutation, equivalent to wild-type. IRS2-amplification APCR564 mutation, TP53 loss (R273H, R213) (Caris-tissue analysis) |
| 14 | Regional hospital March 27, 2006 | Adenocarcinoma of the colon, moderately differentiated. KRAS wild-type | Regional radiology CT June 2008 | Pulmonary nodule | Hemicolectomy March 23, 2006 |
|
|
|
|
|
|
|
|
|
|
| FOLFOX June 2006 to December 2006 | Regional radiology CT October 2008 | Recurrence (lungs) |
|
|
|